| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/12/2012 | US20120009188 Optimized fc variants |
| 01/12/2012 | US20120009184 Anti-C5 Alpha Antibodies |
| 01/12/2012 | US20120009180 Anti-abeta oligomer humanized antibody |
| 01/12/2012 | US20120009179 ANTI-Aß OLIGOMER HUMANIZED ANTIBODY |
| 01/12/2012 | US20120009178 Tweak binding antibodies |
| 01/12/2012 | US20120009175 Method of Using Salmon Thrombin to Alleviate Pain |
| 01/12/2012 | US20120009171 Methods and compositions for cns delivery of arylsulfatase a |
| 01/12/2012 | US20120009169 Self-forming phospholipidic gels |
| 01/12/2012 | US20120009163 Means and methods for activating vagus nerve |
| 01/12/2012 | US20120009160 Cells for the treatment of nervous system disorders |
| 01/12/2012 | US20120009157 Culture method of embryoid bodies and/or neural stem cells derived from human differentiated cell-derived pluripotent stem cells |
| 01/12/2012 | US20120009152 Nitric oxide donors for treatment of disease and injury |
| 01/12/2012 | US20120009131 Method for preventing or treating amyloid beta peptide-associated diseases or conditions, and method for inhibiting formation, accumulation or aggregation of amyloid beta peptides |
| 01/12/2012 | US20120009129 Pharmaceutical compositions for deterring misuse, abuse, and diversion |
| 01/12/2012 | US20120009125 Apoe4 and apoj biomarker-based prevention and treatment of dementia |
| 01/12/2012 | US20120006716 Humanized anti-il-6 antibodies |
| 01/12/2012 | DE102010026903A1 Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff Transdermal therapeutic system with avocado oil or palm oil as an adjuvant |
| 01/12/2012 | CA2804918A1 N-hydroxyformamide derivative and medicament containing same |
| 01/12/2012 | CA2804329A1 Bisaryl (thio)morpholine derivatives as s1p modulators |
| 01/12/2012 | CA2804285A1 Bipyridyl derivatives useful for the treatment of kinase - induced diseases |
| 01/12/2012 | CA2804173A1 Sulfonamide nav1.7 inhibitors |
| 01/12/2012 | CA2804165A1 Piperidinyl pyrimidine amides as kv7 potassium channel openers |
| 01/12/2012 | CA2804161A1 Pro-neurogenic compounds |
| 01/12/2012 | CA2804143A1 Spiro-cyclic amine derivatives as s1p modulators |
| 01/12/2012 | CA2804137A1 Fused heterocyclic derivatives as s1p modulators |
| 01/12/2012 | CA2803717A1 (3-methylpyrrolidin-3-yl) methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists |
| 01/12/2012 | CA2803545A1 Prokineticin 1 receptor antagonists for the treatment of pain |
| 01/12/2012 | CA2803539A1 Prokineticin 1 receptor antagonists for the treatment of pain |
| 01/12/2012 | CA2803118A1 Sulfonamide derivatives as nav 1.7 inhibitors |
| 01/12/2012 | CA2802832A1 Therapeutic agents 976 |
| 01/12/2012 | CA2802133A1 Use of 5.alpha.-androstane(alkyl)-3.beta.,5,6.beta.-triol in preparation of neuroprotective drugs |
| 01/12/2012 | CA2801620A1 Novel gastro-retentive dosage forms comprising a gaba analog and an opioid |
| 01/12/2012 | CA2801583A1 Anellated pyridine compounds |
| 01/11/2012 | EP2404923A1 7-azabicyclo[2.2.1]heptane derivatives useful for promoting smoking cessation |
| 01/11/2012 | EP2404918A1 Pyridine derivative |
| 01/11/2012 | EP2404613A1 Novel uses of fibrinogen-420 and active domain thereof |
| 01/11/2012 | EP2404603A1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds for the treatment of CSBP/p38 kinase mediated diseases |
| 01/11/2012 | EP2404599A1 Neuroprotective compounds |
| 01/11/2012 | EP2403871A1 Antibodies and epitopes specific to misfolded prion protein |
| 01/11/2012 | EP2403859A2 Molecular tweezers for the treatment of amyloid-related diseases |
| 01/11/2012 | EP2403854A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products |
| 01/11/2012 | EP2403853A1 Pyrrolopyrimidines used as kinase inhibitors |
| 01/11/2012 | EP2403850A1 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation |
| 01/11/2012 | EP2403839A2 Neurotrophin mimetics and uses thereof |
| 01/11/2012 | EP2403835A1 Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators |
| 01/11/2012 | EP2403830A2 Indole derivatives for treating neurodegenerative diseases |
| 01/11/2012 | EP2403534A1 Pharmaceutical compositions active in preventing, stabilizing and treating alzheimer's disease |
| 01/11/2012 | EP2403512A2 Compositions of polymeric myrcene |
| 01/11/2012 | EP2403505A2 Therapeutic uses of mastic gum fractions |
| 01/11/2012 | EP2403501A1 Pregnenolone sulfate for the treatment of neurologic disorders |
| 01/11/2012 | EP2403491A2 Alkylglycerols and alkoxyglycerols for increasing endogenous plasmalogen levels in mammals |
| 01/11/2012 | EP2403485A2 Pharmaceutical composition containing rasagiline mesylate |
| 01/11/2012 | EP2403482A1 Abuse resistant formulation |
| 01/11/2012 | EP2403340A1 Compounds and compositions for cognition-enhancement, methods of making, and methods of treating |
| 01/11/2012 | EP2403337A2 Alkylsulfonyl-2,3-dihydrospiro[indene-1,4'-piperidine] analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders |
| 01/11/2012 | EP2152690B1 Pyridyl piperidine orexin receptor antagonists |
| 01/11/2012 | EP2150534B1 Isoquinolinone derivatives as nk3 antagonists |
| 01/11/2012 | EP2131662B1 Process of producing tomato paste |
| 01/11/2012 | EP2054515B1 Use of a phage displaying a peptide from an adhesion protein for treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 01/11/2012 | EP2044043B1 1- ý[- (2, 4-dimethylphenylsulfanyl) -phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment |
| 01/11/2012 | EP2037928B1 Methods for treating atherosclerosis |
| 01/11/2012 | EP1948215B1 MacroH2A non-histone domain as inhibitor of PARP-1 activity and uses thereof |
| 01/11/2012 | EP1809597B1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 01/11/2012 | EP1763518B1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 01/11/2012 | EP1572074B1 Stabilized synthetic immunogen delivery system |
| 01/11/2012 | EP1458687B1 Pyrimidine compounds as interleukin-12 (il-12) inhibitors |
| 01/11/2012 | CN102317302A Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics |
| 01/11/2012 | CN102317301A Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics |
| 01/11/2012 | CN102317289A Lactams as beta secretase inhibitors |
| 01/11/2012 | CN102317273A (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives |
| 01/11/2012 | CN102317270A Isoxazole-isoxazole and isoxazole-isothiazole derivatives |
| 01/11/2012 | CN102317261A Triple reuptake inhibitors and methods of their use |
| 01/11/2012 | CN102316902A Glutathione-based drug delivery system |
| 01/11/2012 | CN102316873A Compounds and methods for enhancing erythropoiesis |
| 01/11/2012 | CN102316865A L-lysine for improving normal cognitive functions |
| 01/11/2012 | CN102316863A Medical use of 5-benzylaminosalicylic acid derivatives or salts thereof |
| 01/11/2012 | CN102311481A Methyl toonapubesate A and preparation method as well as application thereof |
| 01/11/2012 | CN102311454A Compound lipid containing porphyrin ring functional groups, intermediate, preparation method and application thereof |
| 01/11/2012 | CN102311448A Thieno-pyrimidone DPP-IV (dipeptidyl peptidase) inhibitor |
| 01/11/2012 | CN102311447A Heterocyclo pyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitor |
| 01/11/2012 | CN102311432A Stable vinpocetine compound and pharmaceutical composition thereof |
| 01/11/2012 | CN102311430A Novel crystalline state of iloperidone and preparation method thereof |
| 01/11/2012 | CN102311416A Hydroxy substituted flavonoid compound, preparation method and application thereof |
| 01/11/2012 | CN102311398A Triazole compounds, preparation method thereof, and application thereof in preparing histone deacetylase I inhibitor |
| 01/11/2012 | CN102311396A Pyrazine derivative and preparation method as well as application thereof to pharmacy |
| 01/11/2012 | CN102311387A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 01/11/2012 | CN102311385A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 01/11/2012 | CN102309767A Soluble osthole clathrate, dispersing tablet and preparation method thereof |
| 01/11/2012 | CN102309752A Protein related to brain ageing and Alzheimer's disease and application thereof |
| 01/11/2012 | CN102309735A Traditional Chinese medicine powder for treating epilepsy |
| 01/11/2012 | CN102309733A Traditional Chinese medicine decoction for treating insomnia and amnesia |
| 01/11/2012 | CN102309702A Traditional Chinese medicine decoction for treating sciatica |
| 01/11/2012 | CN102309690A Traditional Chinese medicine decoction for treating poliomyelitis |
| 01/11/2012 | CN102309689A Gastrodia elata chewing gum agent, preparation method and detection method thereof |
| 01/11/2012 | CN102309686A Medicinal composition for rehabilitation and application thereof |
| 01/11/2012 | CN102309634A Hypnotic Chinese medicinal preparation for external use |
| 01/11/2012 | CN102309632A Application of pharmaceutical composition in preparation of pharmaceuticals for treating complications of diabetes |
| 01/11/2012 | CN102309618A Traditional Chinese medicine decoction for treating hand and foot numbness |
| 01/11/2012 | CN102309617A Traditional Chinese medicine decoction for treating prosopalgia |
| 01/11/2012 | CN102309609A Traditional Chinese medicine pill for treating night sweats |